Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

69
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the Role of miR-33a-5p in Bladder Cancer Progression: Clinical Significance and Functional Pathways.

Combinatorial chemistry & high throughput screening·2026
Same author

Innovations in Depression Diagnosis and Treatment: A Review of Biological, Cognitive, and Psychosocial Advances.

Current topics in medicinal chemistry·2026
Same author

CCNJL as a Prognostic Biomarker and Therapeutic Target in Cholangiocarcinoma.

Current medicinal chemistry·2026
Same author

Research Progress on Desmoid Tumors: New Perspectives from Molecular Mechanisms to Clinical Management.

Anti-cancer agents in medicinal chemistry·2026
Same author

From Biomarker to Drug Target: Integrating ceRNA Networks and Pharmacogenomics to Reposition C5orf34 in Uterine Corpus Endometrial Cancer Therapy.

Current medicinal chemistry·2026
Same author

Chikungunya Virus (CHIKV) Pathogenesis: From Acute Fever to Chronic Arthritis-Immune Mechanisms and Therapeutic Implications.

Current topics in medicinal chemistry·2026

Related Experiment Video

Updated: Apr 7, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K

Decoding Sarcoma Drug Resistance: From Molecular Mechanisms to Precision Interventions.

Guizhen Lyu1, Dongbing Li2

  • 1Dongguan Key Laboratory of Clinical Medical Test Diagnostic Technology for Oncology, Dongguan Labway Clinical Laboratory Co., Ltd., Dongguan, 523429, Guangdong, China.

Anti-Cancer Agents in Medicinal Chemistry
|April 6, 2026
PubMed
Summary
This summary is machine-generated.

Sarcoma drug resistance is complex, involving molecular and microenvironmental factors. Precision medicine strategies, combining mechanistic insights with biomarker-guided therapies, offer a promising approach to improve patient outcomes.

Keywords:
Sarcoma heterogeneitybiomarker- guided treatment.combination strategiesdrug resistance mechanismsprecision therapytumor microenvironment

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K

Related Experiment Videos

Last Updated: Apr 7, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

11.3K
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.7K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

14.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Sarcomas exhibit multifaceted drug resistance.
  • Understanding resistance mechanisms is crucial for effective treatment.

Purpose of the Study:

  • To systematically review sarcoma drug resistance mechanisms.
  • To evaluate precision medicine strategies against these mechanisms.

Main Methods:

  • Comprehensive literature review of sarcoma, drug resistance, and precision medicine.
  • Categorization of resistance pathways and therapeutic countermeasures.

Main Results:

  • Key resistance drivers include ABC transporters, DNA repair, secondary mutations, and immune evasion.
  • Emerging strategies involve next-generation TKIs, dual-pathway inhibitors, and chemo-immuno combinations.
  • Liquid biopsies (ctDNA) aid resistance monitoring.

Conclusions:

  • Integrating multi-omics, liquid biopsies, and organoids can personalize sarcoma therapy.
  • Biomarker-guided combination/sequential therapies are vital for overcoming resistance.